Russia approves their second Covid-19 vaccine

Covid-19 vaccine
The EpiVacCorona vaccine's approval comes ahead of post-registration trials involving 40,000 volunteers across Russia. | Photo: Moskva News Agency

Moscow, Russia — The President of Russia, Vladimir Putin announced on Wednesday, that a regulatory approval has been granted for the country’s second Covid-19 vaccine.

In a television video conference, Putin announced that the State Virology and Biotechnology Center, Novosibirsk’s Vektor has registered what would be the second Russian Covid-19 vaccine. According to Putin, the Deputy Prime Minister Tatyana Golikova and the head of Russia’s consumer safety watchdog, Anna Popova have recieved the second Russian Vaccine, ‘EpiVacCorona’ as part of clinical trials.

The early trial that was conducted on a 100 volunteers was said to be successful as well. However, the post-registration trials of EpiVacCorona must have 40,000 volunteers to be involved throughout Russia. Therefore, the Vektor revealed that they hope to produce the first 60,000 doses of EpiVacCorona “in the nearest future.”

The health officials have revealed no information and has declined to answer questions about EpiVacCorona’s initial trial results or the approval process. They stated that they were reviewing the vaccine for safety and quality.

Russia’s first vaccine named Sputnik V was approved by Putin and it begun its large-scale trials on 40,000 volunteers in September. The Phase 3 trials of this vaccine is expected to be finished during the summer of 2021.